Bo Norrving Editor

Bo Norrving is Professor of Neurology at Lund University, Sweden. He was corresponding author of the Swedish Aspirin Low-Dose Trial (SALT) (Lancet, 1991), the first trial demonstrating the benefit of low dose aspirin therapy for the prevention of stroke. He pioneered the assessment of cerebral hemodynamics by blood flow techniques, clinical syndromes of cerebellar stroke and lacunar infarcts, the importance of silent small vessel disease in the brain, and recognition of dissection as a major cause of stroke in the young. He is Chair of the steering committee of SIFAP, and a founder of Riks-Stroke, the world's first national stroke registry. He is Senior Consulting Editor of Stroke, Associate Editor of Neuroepidemiology, and member of several editorial boards. Bo Norrving was the President of the World Stroke Organisation between 2008 and 2012 and still represents the society at the WHO and UN. He chairs the Cerebrovascular Committee for the revision of the ICD 11 at the WHO.